75 related articles for article (PubMed ID: 22157696)
21. Dihydrofolate reductase activity in the erythroblasts of patients with 5q- syndrome.
Nano R; Invernizzi R; Pecci A; Civallero M; Gerzeli G
Haematologica; 2000 Jul; 85(7):765-6. PubMed ID: 10897132
[No Abstract] [Full Text] [Related]
22. Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome.
Knipp S; Strupp C; Gattermann N; Hildebrandt B; Schapira M; Giagounidis A; Aul C; Haas R; Germing U
Leuk Res; 2008 Jan; 32(1):33-7. PubMed ID: 17412418
[TBL] [Abstract][Full Text] [Related]
23. Triplication of 1q in Fanconi anemia.
Ferro MT; Vazquez-Mazariego Y; Ramiro S; Sanchez-Hombre MC; Villalon C; Garcia-Sagredo JM; Ulibarrena C; Sastre JL; Roman CS
Cancer Genet Cytogenet; 2001 May; 127(1):38-41. PubMed ID: 11408063
[TBL] [Abstract][Full Text] [Related]
24. The 5q- syndrome.
Van den Berghe H
Scand J Haematol Suppl; 1986; 45():78-81. PubMed ID: 3457446
[No Abstract] [Full Text] [Related]
25. Duplication of (12)(pter-q13.3) combined with deletion of (22)(pter-q11.2) in a patient with features of both chromosome aberrations.
Tyshchenko NA; Riegel M; Evseenkova EG; Zerova TE; Gorovenko NG; Schinzel A
Eur J Med Genet; 2007; 50(2):128-32. PubMed ID: 17174617
[TBL] [Abstract][Full Text] [Related]
26. Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: differential diagnosis between refractory anemia and aplastic anemia.
Iwasaki T; Murakami M; Sugisaki C; Sobue S; Ohashi H; Asano H; Suzuki M; Nakamura S; Ito M; Murate T
Pathol Int; 2008 Jun; 58(6):353-60. PubMed ID: 18477214
[TBL] [Abstract][Full Text] [Related]
27. Cytogenetic characteristics and prognosis analysis in 231 myelodysplastic syndrome patients from a single institution.
Jung SW; Lee SY; Jekarl DW; Kim M; Lim J; Kim Y; Han K; Kim YJ; Cho SG; Song J
Leuk Res; 2011 Jun; 35(6):735-40. PubMed ID: 21146871
[TBL] [Abstract][Full Text] [Related]
28. New chromosome aberration: duplication of a large part of chromosome 4q and partial deletion of chromosome 1q.
Merlob P; Kohn G; Litwin A; Nissenkorn I; Katznelson MB; Reisner SH
Am J Med Genet; 1989 Jan; 32(1):22-6. PubMed ID: 2705479
[TBL] [Abstract][Full Text] [Related]
29. Translocation (1;22) in refractory anemia and the prognostic significance of karyotypic abnormalities in refractory anemia.
Keung YK; Cobos E; Tonk V; Morgan D
Cancer Genet Cytogenet; 1998 Oct; 106(1):72-5. PubMed ID: 9772913
[TBL] [Abstract][Full Text] [Related]
30. 1q triplication as sole cytogenetic abnormality in myelodysplastic syndrome.
Ha JS; Choi MS
Leuk Lymphoma; 2011 Jul; 52(7):1387-9. PubMed ID: 21599583
[No Abstract] [Full Text] [Related]
31. [Terminal 1q deletion by translocation t(1;20)pat, confirmed by in situ hybridization].
López-Ginés C; Gil-Benso R; Gregori-Romero MA; Paredes-Cencillo C; Castelló-Pomares M; Llombart-Bosch A
An Esp Pediatr; 1998 Mar; 48(3):309-11. PubMed ID: 9608096
[No Abstract] [Full Text] [Related]
32. Recurrent unbalanced whole-arm t(1;10)(q10;p10) in myelodysplastic syndrome: a case report and literature review.
Odish OF; Gotoh A; Liu YC; Shoji N; Kimura Y; Kodama A; Ohyashiki K
Cancer Genet Cytogenet; 2007 Jan; 172(2):165-7. PubMed ID: 17213027
[TBL] [Abstract][Full Text] [Related]
33. Molecular cytogenetic determination of a deletion/duplication of 1q that results in a trisomy 18 syndrome-like phenotype.
Mewar R; Harrison W; Weaver DD; Palmer C; Davee MA; Overhauser J
Am J Med Genet; 1994 Aug; 52(2):178-83. PubMed ID: 7802005
[TBL] [Abstract][Full Text] [Related]
34. A yet unreported der(11)t(6;11)(p21;q21) included in a complex karyotype of a refractory anemia with ring sideroblasts and poor prognosis.
de Souza DC; de Figueiredo AF; Mkrtchyan H; Othman MA; Liehr T; Dobbin J; Silva ML; Abdelhay E; Fernandez Tde S
Blood Cells Mol Dis; 2014; 53(1-2):91-3. PubMed ID: 24439112
[No Abstract] [Full Text] [Related]
35. Response to lenalidomide of a patient with t(2;3)(p23;q29) and JAK2 non-mutated refractory anemia with ring sideroblasts and thrombocytosis.
Zhang M; You Y; Li X; He Y; Zheng J; Li W; Zou P; Liu X; Liu F
Leuk Lymphoma; 2013 Jul; 54(7):1544-6. PubMed ID: 23252419
[No Abstract] [Full Text] [Related]
36. Hypoplastic myelodysplastic syndrome associated with der(1;7)(q10;p10) presenting as bone marrow failure.
Cho SY; Oh SH; Suh JT; Lee HJ; Lee WI; Baek SK; Cho KS; Park TS
Acta Haematol; 2011; 126(2):110-3. PubMed ID: 21646778
[No Abstract] [Full Text] [Related]
37. Chromosome studies in human hematologic diseases: II. Myelodysplastic syndromes.
Larripa I; Labal de Vinuesa M; Bengiò R; Slavutsky I
Haematologica; 1987; 72(5):399-403. PubMed ID: 3121461
[No Abstract] [Full Text] [Related]
38. A 46, XY, dup (1) (q21q32), add(11) (q23) karyotype in a case of Fanconi anemia.
Babu Rao V; Kerketta L; Ghosh K; Mohanty D
Leuk Res; 2001 Apr; 25(4):347-8. PubMed ID: 11248332
[No Abstract] [Full Text] [Related]
39. Alleviation of myelodysplastic syndrome-associated skin rush after treatment with decitabine.
Papaioannou M; Sapalidis K; Kotoula V
Eur J Haematol; 2008 Dec; 81(6):489-90. PubMed ID: 18691250
[No Abstract] [Full Text] [Related]
40. A case of refractory anemia with 17p- syndrome following azathioprine treatment for heart transplantation.
Depil S; Lepelley P; Soenen V; Preudhomme C; Lai JL; Broly F; Quesnel B
Leukemia; 2004 Apr; 18(4):878. PubMed ID: 14961032
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
